文献速递脑血管病

急性缺血性卒中血栓迁移悖论

Thrombus Migration Paradox in Patients With Acute Ischemic Stroke.
PubMed 文献 · Stroke · 2019-10-10

基于MR CLEAN注册研究,纳入1349例前循环大血管闭塞患者,比较CT血管造影与数字减影血管造影所见血栓位置变化。血栓迁移发生率为22%,静脉阿替普酶治疗与迁移和溶解增加相关;迁移降低完全再灌注率,但在M1初始闭塞亚组中与更好功能结局相关。

要点

  • 血栓位置在CTA与DSA间常发生变化,迁移发生率约22%。
  • 静脉阿替普酶增加血栓迁移和溶解的概率。
  • 血栓迁移降低完全再灌注率,但M1闭塞者功能结局更好。

核心结论

  • 急性缺血性卒中患者血栓位置在CTA与DSA之间常有变化,静脉阿替普酶增加迁移和溶解,迁移降低完全再灌注但可能改善功能结局。

研究设计与样本

  • 基于MR CLEAN注册研究,纳入1349例CTA显示颅内ICA、M1或M2初始目标闭塞的患者,常规造影目标闭塞在血管内治疗中定义。

主要发现

  • 血栓迁移发生302例(22%),血栓增长87例(6%),血栓溶解39例(3%)。
  • 静脉阿替普酶与更多血栓迁移相关(调整OR 2.01;CI 1.29-3.11)和更多血栓溶解相关(调整OR 1.85;CI 1.22-2.80)。
  • 血栓迁移与完全再灌注几率降低相关(调整OR 0.57;CI 0.42-0.78)和成功再灌注几率降低相关(调整OR 0.74;CI 0.55-0.99)。
  • 在M1初始目标闭塞亚组中,血栓迁移与更好功能结局相关(调整common OR 1.49;CI 1.02-2.17),血栓溶解有更好功能结局趋势(调整common OR 2.23;CI 0.93-5.37)。

临床怎么用

  • 血管内治疗前应意识到血栓位置可能已变化,静脉溶栓后迁移常见。
  • 血栓迁移可能降低完全再灌注率,但M1闭塞者迁移或提示功能结局更好。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- The location of the thrombus as observed on first digital subtraction angiography during endovascular treatment may differ from the initial observation on initial noninvasive imaging. We studied the incidence of thrombus dynamics, its impact on patient outcomes, and its association with intravenous thrombolytics. Methods- We included patients from the MR CLEAN registry (Multicenter Randomized Clinical Trial of Endovascular Treatment of Acute Ischemic Stroke) with an initial target occlusion on computed tomography angiography located in the intracranial internal carotid artery, M1, or M2. The conventional angiography target occlusion was defined during endovascular treatment. Thrombus dynamics were classified as growth, stability, migration, and resolution. The primary outcome was functional outcome at 90 days (modified Rankin Scale). The secondary outcomes were successful and complete reperfusion (extended treatment in cerebral infarction scores of 2b-3 and 3, respectively). Results- The analysis included 1349 patients. Thrombus migration occurred in 302 (22%) patients, thrombus growth in 87 (6%), and thrombus resolution in 39 (3%). Intravenous treatment with alteplase was associated with more thrombus migration (adjusted odds ratio, 2.01; CI, 1.29-3.11) and thrombus resolution (adjusted odds ratio, 1.85; CI, 1.22-2.80). Thrombus migration was associated with a lower chance of complete reperfusion (adjusted odds ratio, 0.57; CI, 0.42-0.78) and successful reperfusion (adjusted odds ratio, 0.74; CI, 0.55-0.99). In the subgroup of patients with M1 initial target occlusion, thrombus migration was associated with better functional outcome (adjusted common odds ratio, 1.49; CI, 1.02-2.17), and there was a trend towards better functional outcome in patients with thrombus resolution (adjusted common odds ratio, 2.23; CI, 0.93-5.37). Conclusions- In patients with acute ischemic stroke, thrombus location regularly changes between computed tomography angiography and digital subtraction angiography. Administration of intravenous alteplase increases the chance of thrombus migration and resolution. Thrombus migration is associated with better functional outcome but reduces the rate of complete reperfusion.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Alves HC, Treurniet KM, Jansen IGH, et al. Thrombus Migration Paradox in Patients With Acute Ischemic Stroke. Stroke. 2019. PMID: 31597552. doi:10.1161/STROKEAHA.119.026107

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。